Skip to main content

Table 1 List of drugs and drug classes covered, corresponding indications and SRs performed

From: A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol

Drug or drug class

Indication

Proton pump inhibitors

GERD/GORD (SR-1)

Gastrointestinal ulcer (gastric, duodenal) (SR-1)

Dyspepsia (SR-1)

Anti- inflammatory and anti- rheumatic products, non-steroids (NSAIDs)

Musculoskeletal disorders (SR-2)

Opioids

Pain (SR-3)

HMG CoA reductase inhibitors (Statins)

Prevention of cardiovascular disease (SR-4)

Beta blocking agents

Hypertension (SR-5)

Heart failure (SR-6)

Angiotensin Converting Enzyme inhibitors (ACE-I)

Hypertension (SR-7)

Low-ceiling diuretics, Thiazides and Sulfonamides

Heart failure (SR-8)

Oedema (SR-8)

Hypertension (SR-9)

Calcium Channel Blockers (CCBs)

Angina (SR-10)

Hypertension (SR-11)

Nitrates

Angina (SR-12)

High ceiling diuretics

Heart failure (SR-13)

Oedema (SR-13)

Hypertension (SR-13)

Liver failure (SR-13)

Renal failure (SR-13)

Platelet aggregation inhibitors

Prevention and treatment of cardiovascular disease including cerebral infarction and transient ischaemic attack, coronary disease and peripheral artery occlusive disease (SR-14)

Vitamin K antagonists (VKA) Direct thrombin inhibitors and Direct factor Xa inhibitors (New Oral Anticoagulants (NOACs))

Deep vein thrombosis/lung embolism (SR-15)

Thromboembolism in atrial fibrillation (SR-16)

Digitalis glycosides

Heart failure (SR-17)

Atrial fibrillation (SR-17)

Metformin

Type 2 diabetes (SR-18)

Dipeptidyl peptidase 4 (DPP-4) inhibitors (Gliptins)

Type 2 diabetes (SR-19)

Pioglitazone

Type 2 diabetes (SR-20)

Sulfonylureas

Type 2 diabetes (SR-21)

Glinides

Type 2 diabetes (SR-21)

Insulin and analogues

Type 2 diabetes (SR-22)

  1. GERD gastroesophageal reflux disease, GORD gastro-oesophageal reflux disease, HMG CoA 3-hydroxy-3-methylglutaryl-coenzyme A, Direct factor Xa inhibitors xabans